Samsung Biologics union stages partial strike, output at risk

Unionized workers at Samsung Biologics, a major contract drug manufacturer, launched another partial strike on Nov. 6, continuing labor action that could disrupt production. The strike's scope and impact on output remain unclear, but it adds operational risk to a key global biopharma supply chain player.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works